Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone
AUTOR(ES)
Mukhina, Svetlana
FONTE
National Academy of Sciences
RESUMO
We report here that autocrine production of human growth hormone (hGH) results in a phenotypic conversion of mammary carcinoma cells such that they exhibit the morphological and molecular characteristics of a mesenchymal cell, including expression of fibronectin and vimentin. Autocrine production of hGH resulted in reduced plakoglobin expression and relocalization of E-cadherin to the cytoplasm, leading to dissolution of cell-cell contacts and decreased cell height. These phenotypic changes were accompanied by an increase in cell motility, elevated activity of specific matrix metalloproteinases, and an acquired ability to invade a reconstituted basement membrane. Forced expression of plakoglobin significantly decreased mammary carcinoma cell migration and invasion stimulated by autocrine hGH. In vivo, autocrine hGH stimulated local invasion of mammary carcinoma cells concomitant with a prominent stromal reaction in comparison with well delineated and capsulated growth of mammary carcinoma cells lacking autocrine production of hGH. Thus, autocrine production of hGH by mammary carcinoma cells is sufficient for generation of an invasive phenotype. Therapeutic targeting of autocrine hGH may provide a mechanistic approach to prevent metastatic extension of human mammary carcinoma.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=524067Documentos Relacionados
- Gradual Phenotypic Conversion Associated with Immortalization of Cultured Human Mammary Epithelial Cells
- Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone.
- Correlation between hormone dependency and the regulation of epidermal growth factor receptor by tumor promoters in human mammary carcinoma cells.
- Growth hormone-releasing hormone: An autocrine growth factor for small cell lung carcinoma
- The oncogenic potential of autocrine human growth hormone in breast cancer